The global next generation sequencing market is expected to reach USD 19.70 billion by 2025 registering a CAGR of 12.78%, according to a new report by Grand View Research, Inc. Growing application of NGS methodologies due to rising number of strategic developments initiated by the market participants is one of the key drivers of the market. These novel strategies mark the presence of intense competition between the key firms. Companies are further increasing their installation base by providing sequencing services in different emerging countries. For instance, in April 2018, Illumina entered into a partnership with Loxo Oncology for the development of Illumina TruSight Tumor 170 NGS test as a companion diagnostic for Loxo Oncology’s LOXO-292 and larotrectinib for tumor profiling.
Similarly, in March 2018, PierianDx partnered with cancer genetics to offer NGS-based tests for oncology precision medicine. NGS technologies experience significant growth due to rapid automation in the pre-sequencing protocols and advancements in clinical diagnosis and disease testing. Wide application of this technique in oncology, reproductive screening, infectious disease, noninvasive prenatal testing, and pharmacogenomics is also expected to positively impact the market growth. Reduced costs of genetic sequencing has also significantly enhanced the adoption of these technologies. Reduced installation costs of NGS platforms and easy availability of proteomic and genomic data has also resulted in an increased demand, thereby propelling the market development.
Browse Details of Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/asia-pacific-nutritional-supplements-market
Key Takeaways from the report:
Request For Free Sample Report @ https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market/request/rs4 Table of Contents
Chapter 1 Research Methodology & Scope 1.1 Information Procurement 1.1.1 Purchased database: 1.1.2 GVR’s internal database 1.1.3 Secondary sources: 1.1.4 Third Party Perspective: 1.1.5 Primary Research: 1.2 Information or Data Analysis 1.3 Market Formulation & Validation 1.4 Region Wise Market Calculation 1.4.1 Region wise market: Base estimates 1.4.2 Global market: CAGR calculation 1.4.3 Region based segment share calculation Chapter 2 Executive Summary 2.1 Next Generation Sequencing Market Outlook, 2014 – 2025 2.2 Next Generation Sequencing Market : Segment Outlook, 2014 – 2025 2.3 Next Generation Sequencing Market : Competitive Insights Chapter 3 Next Generation Sequencing Market Variables, Trends, & Scope 3.1 Market Lineage Outlook 3.1.1 Parent market outlook 3.1.2 Related/ancillary market outlook 3.2 Penetration & Growth Prospect Mapping for Applications, 2018 3.3 Penetration & Growth Prospect Mapping for Prominent Industry Players, 2018 3.4 Product Pipeline Analysis, by Stage 3.5 Cost Structure Analysis 3.6 User Perspective Analysis 3.6.1 Consumer behavior analysis 3.6.2 Market influencer analysis 3.7 Procedure Cost Analysis 3.8 End-use analysis 3.9 Technology Overview 3.9.1 Technology timeline 3.10 Regulatory Framework 3.10.1 Next generation sequencing reimbursement scenario 3.10.1.1 Gap fill approach for reimbursement of NGS tests 3.10.1.2 Role of the commercial payers 3.10.1.2.1 Payer perspectives for developing coverage policy for Next Generation Tumor Sequencing Panels (NGTS)
Browse Related Reports :
Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology, By Workflow, By Application, By End Use, By Region, And Segment Forecasts, 2019 – 2025
https://www.grandviewresearch.com/industry-analysis/clinical-oncology-next-generation-sequencing-ngs-market
U.S. Clinical Oncology Next Generation Sequencing (NGS) Market Size & Forecast By Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), By Workflow (NGS Pre-Sequencing, Sequencing, NGS Data Analysis, Primary, Secondary & Tertiary Data Analysis), By End Use (Academic & Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities) And Trend Analysis From 2018 To 2024
https://www.grandviewresearch.com/industry-analysis/us-clinical-oncology-next-generation-sequencing-ngs-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market